	Phase I/II clinical trial of a melanoma vaccine targeting shared non-mutated antigens and a shared mutated BRAF neoantigen with an agonistic CD40 antibody (CDX-1140) plus TLR3 agonist (poly-ICLC). J Immunother Cancer Ninmer EK, Petroni GR, Gastman BR, Gaughan EM, Isaacs JM, Haden K, Kaur V, Wages NA, Chianese-Bullock KA, Smith KT, Wright P, Bryant J, Dunlap-Brown M, Engel JA, Bekiranov S, Mauldin IS, Truong TG, Bullock TNJ, Slingluff CL Jr. PMID: 41775435 [PubMed - in process]
	Occupational Sun Exposure and Melanoma Development: A Review of the Evidence. Australas J Dermatol Whiteman DC, Williams GJ, Thompson JF. PMID: 41772818 [PubMed - as supplied by publisher]
	Revealing the Physician's Task Conceptualization in Melanoma Treatment: Qualitative User Experience Study. JMIR Cancer Hartmann EM, Küper A, Swoboda J, Beckmann CL, Lodde GC, Livingstone E, Schadendorf D, Sachweh S. PMID: 41770590 [PubMed - in process]
	A phase 2 study of abemaciclib in patients with brain metastases secondary to non-small cell lung cancer or melanoma. Neurooncol Adv Sahebjam S, Bazer DA, Rhun EL, Queirolo P, Jerusalem G, Johnston EL, Conte P. PMID: 41768125 [PubMed]
	Tumor immune-vascular crosstalk: synergy and translation of immune checkpoint inhibitors and anti-angiogenic agents in melanoma. Front Immunol Xie Y, Ho I, Liu Z, Chen K, Zhou M, Ha G, Duan L, Zhao Z, Cai D. PMID: 41766910 [PubMed - in process]
	Ultrasonographic and histopathological correlation in choroidal melanoma: survival outcomes from a single-center study in Serbia. Melanoma Res Vasovi, Ra, Da, Kalezi, Kuzmanovi, Simonovi, Vasilijevi, Kova, Petrovi, Marjanovi. PMID: 41766297 [PubMed - as supplied by publisher]
	Recent advances in the molecular genetic mechanisms and immune microenvironment of uveal melanoma. Melanoma Res Yang K, Wu D. PMID: 41766295 [PubMed - as supplied by publisher]
	Comment On "Pilot Study of Immediate Lymphatic Reconstruction (ILR) During Lymph Node Dissection for Node-Positive Melanoma: Feasibility, Safety, and Early Outcomes". J Surg Oncol Zhang Y, Li C, Shan L. PMID: 41766105 [PubMed - as supplied by publisher]
	Pharmaceutical insights into nanoscale drug delivery systems and chromatographic approaches for melanoma treatment. J Pharm Biomed Anal Deljavan Ghodrati A, Gebrehiwot W, Amasya G, Gumustas M, Sengel-Turk CT. PMID: 41762483 [PubMed - as supplied by publisher]
	PROTAC-based protein degradation: a window of opportunity for melanoma therapy. J Biomed Sci Gentile G, D'Aguanno S, Di Martile M, Petricca A, Valentini E, Scalera S, Del Bufalo D. PMID: 41761284 [PubMed - in process]
	Prognostic factors and treatment outcomes in female genital tract melanoma: a 10-year retrospective cohort study. World J Surg Oncol Mao M, Wang C, Yang W, Zuo Z, Liu B. PMID: 41761233 [PubMed - as supplied by publisher]
	Attenuated Salmonella as a PD-1/PD-L1 SiRNA delivery system for colorectal cancer, hepatocellular carcinoma, and melanoma: A systematic review. Curr Res Transl Med El-Kholy O, Guy M, Elsayed AAR, Basson MD. PMID: 41759482 [PubMed - as supplied by publisher]
	Unraveling the Enigma of Melanoma Brain Metastasis: New Molecular Insights and Therapeutic Directions. Int J Mol Sci O'Toole KT, Roan BM, Hardman TM, Phillips PP, VanBrocklin EM, Parkman GL, Holmen SL. PMID: 41752154 [PubMed - in process]
	Decoding the Role of Lipid Metabolism and Membrane Dynamics in Melanoma. Int J Mol Sci Pisanu ME, Iorio E, Facchiano F, Chirico M, Scattoni ML, Tabolacci C. PMID: 41751850 [PubMed - in process]
	Precision Oncology in Ocular Melanoma: Integrating Molecular and Liquid Biopsy Biomarkers. Curr Issues Mol Biol Ka, Gilevska F, Tomi, , Niku. PMID: 41751395 [PubMed]
	Survival Assessment by Central Review vs. Local Investigator in Metastatic Melanoma: A Systematic Review and Meta-Analysis. Cancers (Basel) Eljilany I, Jafari E, Alhumaid A, Eroglu Z, Brohl AS, Karapetyan L, Markowitz J, Khushalani NI, Hwu P, Tarhini AA. PMID: 41749963 [PubMed]
	Synthetic Melanoma Image Generation and Evaluation Using Generative Adversarial Networks. Bioengineering (Basel) Lin PY, Shen Y, Mathew N, Hu R, Huang S, Queen CM, West CE, Ciurea A, Zouridakis G. PMID: 41749783 [PubMed]
	Real-world data on anti-PD-1 plus lenvatinib as a treatment option in pretreated advanced melanoma patients - a retrospective DeCOG study. Eur J Cancer Albrecht LJ, Garnier J, Zaremba A, Brauch L, Brunnert F, Rauschenberg R, Forschner A, Vazquez XG, Mangana J, Erdmann M, Angela Y, Franklin C, Tietze J, Lodde G, Tasdogan A, Seier JA, Roesch A, Ugurel S, Berking C, Gutzmer R, Heinzerling L, Meier F, Mohr P, Hassel JC, Schadendorf D, Livingstone E, Zimmer L. PMID: 41747312 [PubMed - as supplied by publisher]
	Evaluation of Clinical Outcomes and Pattern of Recurrence in Patients with Cutaneous Melanoma and Sentinel Lymph Node Positivity Since the Publication of the MSLT-2 Trial. Ann Surg Oncol Mor E, Apte S, Bressel M, Broman KK, Hieken TJ, Olofsson Bagge R, Berman RS, Lee AY, Kuijpers AM, Ollila DW, van Akkooi ACJ, Zager JS, Gyorki DE. PMID: 41746574 [PubMed - as supplied by publisher]
	Tebentafusp-associated dermatological adverse events in patients with metastatic uveal melanoma: a single-center retrospective cohort study. Melanoma Res Zhou MH, Li W, Carpenter AK, Lipner SR. PMID: 41746214 [PubMed - in process]

Articles 1 - 20 / 141598

Page 1 of 7080



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy